ASX - By Stock
|
EMV |
Re:
Ann: Trial data confirms early ischaemia detection capabilities
|
|
thehero
|
21 |
8.7K |
26 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
21
|
8.7K
|
26
|
|
Charts
|
EMV |
Re:
Chart
|
|
thehero
|
2.8K |
1.6M |
5 |
11/03/24 |
11/03/24 |
Charts
|
2.8K
|
1.6M
|
5
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Board Changes
|
|
thehero
|
17 |
5.9K |
16 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
17
|
5.9K
|
16
|
|
ASX - By Stock
|
HZR |
Re:
Ann: Trading Halt
|
|
thehero
|
101 |
35K |
3 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
101
|
35K
|
3
|
|
ASX - By Stock
|
HZR |
Re:
Ann: Hazer Achieves First Hydrogen and Graphite at CDP
|
|
thehero
|
284 |
71K |
7 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
284
|
71K
|
7
|
|
ASX - By Stock
|
HZR |
Re:
Ann: CDP Reactor Successfully Commissioned
|
|
thehero
|
236 |
78K |
2 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
236
|
78K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
thehero
|
18 |
5.9K |
18 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
18
|
5.9K
|
18
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
thehero
|
20K |
6.8M |
8 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
20K
|
6.8M
|
8
|
|
Charts
|
EMV |
Re:
Chart
|
|
thehero
|
2.8K |
1.6M |
8 |
30/01/24 |
30/01/24 |
Charts
|
2.8K
|
1.6M
|
8
|
|
ASX - By Stock
|
NAN |
Re:
Ann: H1 FY24 trading update and expectations for FY24
|
|
thehero
|
58 |
36K |
1 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
58
|
36K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
thehero
|
969 |
303K |
4 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
969
|
303K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Trial Recruitment Tartget Reached & EMU Unveiled
|
|
thehero
|
7 |
3.7K |
19 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
7
|
3.7K
|
19
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
thehero
|
14 |
4.7K |
8 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
14
|
4.7K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
thehero
|
14 |
4.7K |
25 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
14
|
4.7K
|
25
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
thehero
|
20K |
6.8M |
9 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
20K
|
6.8M
|
9
|
|
ASX - By Stock
|
NAN |
Re:
Ann: Appointment of Non-executive Director
|
|
thehero
|
1 |
934 |
4 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
1
|
934
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Latest Imaging and Clinical Trial Insights
|
|
thehero
|
46 |
15K |
3 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
46
|
15K
|
3
|
|
ASX - By Stock
|
NAN |
Re:
Ann: 2023 Full Year Financial Results
|
|
thehero
|
27 |
18K |
5 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
27
|
18K
|
5
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Latest Imaging and Clinical Trial Insights
|
|
thehero
|
46 |
15K |
38 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
46
|
15K
|
38
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Latest Imaging and Clinical Trial Insights
|
|
thehero
|
46 |
15K |
26 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
46
|
15K
|
26
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Latest Imaging and Clinical Trial Insights
|
|
thehero
|
46 |
15K |
36 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
46
|
15K
|
36
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
thehero
|
20K |
6.8M |
13 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
20K
|
6.8M
|
13
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
thehero
|
20K |
6.8M |
4 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
20K
|
6.8M
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL Intends to Redomicile to US & List all Shares on Nasdaq
|
|
thehero
|
555 |
188K |
5 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
555
|
188K
|
5
|
|
ASX - By Stock
|
HZR |
Re:
Ann: Hazer Strategy Update Presentation
|
|
thehero
|
62 |
21K |
3 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
62
|
21K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
thehero
|
2.6K |
1.2M |
17 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
2.6K
|
1.2M
|
17
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Leadership Transition
|
|
thehero
|
95 |
28K |
19 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
95
|
28K
|
19
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
thehero
|
20K |
6.8M |
7 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
20K
|
6.8M
|
7
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Leadership Transition
|
|
thehero
|
95 |
28K |
6 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
95
|
28K
|
6
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Leadership Transition
|
|
thehero
|
95 |
28K |
7 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
95
|
28K
|
7
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Leadership Transition
|
|
thehero
|
95 |
28K |
2 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
95
|
28K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Leadership Transition
|
|
thehero
|
95 |
28K |
6 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
95
|
28K
|
6
|
|
ASX - By Stock
|
HZR |
Re:
Ann: HZR Advances Engie Collaboration For a Facility in France
|
|
thehero
|
22 |
8.9K |
6 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
22
|
8.9K
|
6
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
thehero
|
34 |
11K |
6 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
34
|
11K
|
6
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
thehero
|
2.6K |
1.2M |
8 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
2.6K
|
1.2M
|
8
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
thehero
|
2.6K |
1.2M |
5 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
2.6K
|
1.2M
|
5
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Clinical Trial Stage 1 Enrolment Completed
|
|
thehero
|
46 |
13K |
10 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
46
|
13K
|
10
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
thehero
|
20K |
6.8M |
5 |
10/12/22 |
10/12/22 |
ASX - By Stock
|
20K
|
6.8M
|
5
|
|
ASX - By Stock
|
HZR |
Re:
Ann: HAZER MITSUI SIGN MOU TO JOINTLY INVESTIGATE GRAPHITE MARKET
|
|
thehero
|
42 |
17K |
4 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
42
|
17K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
thehero
|
19 |
6.0K |
10 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
19
|
6.0K
|
10
|
|
ASX - By Stock
|
NTI |
Re:
Ann: BREAKTHROUGH RESULTS WITH NTI164 IN PAEDIATRIC ASD
|
|
thehero
|
33 |
12K |
1 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
33
|
12K
|
1
|
|
Charts
|
EMV |
Re:
Chart
|
|
thehero
|
2.8K |
1.6M |
14 |
17/06/22 |
17/06/22 |
Charts
|
2.8K
|
1.6M
|
14
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
thehero
|
20K |
6.8M |
17 |
05/05/22 |
05/05/22 |
ASX - By Stock
|
20K
|
6.8M
|
17
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Trading Halt
|
|
thehero
|
17 |
9.0K |
30 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
17
|
9.0K
|
30
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
thehero
|
2.6K |
1.2M |
19 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
2.6K
|
1.2M
|
19
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
thehero
|
201 |
83K |
5 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
201
|
83K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
thehero
|
201 |
83K |
7 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
201
|
83K
|
7
|
|
ASX - By Stock
|
IHL |
Re:
IXHL NASDAQ Trading
|
|
thehero
|
356 |
149K |
14 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
356
|
149K
|
14
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
thehero
|
3.0K |
1.1M |
5 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
3.0K
|
1.1M
|
5
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
thehero
|
20K |
6.8M |
1 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
20K
|
6.8M
|
1
|
|